CH
Chung-Bin Hwang
PresidentDr. Chung-Bin Hwang, known as Ben, PhD, was Director of NorthView Acquisition Corporation from June 9, 2025 to July 2025. Dr. Hwang served as the Chairman and Chief Executive Officer of Profusa, Inc. since January 2012 until July 21, 2026, was Director until July 26, 2026 and serves as President since July 21, 2026. Prior to Profusa, Dr. Hwang served in a variety of leadership roles at Life Technologies Corp. (acquired by Thermo Fisher Scientific, Inc.), including President of the Asia Pacific Region and Head of the qPCR Division. Prior to joining Life Technology, Dr. Hwang was a consultant with McKinsey & Company. Dr. Hwang received his M.A. in Biology and Ph.D. in Biology from The Johns Hopkins University.
Positions
- Company NameProfusa, Inc.Stock CodeNVACWPositionPresidentRelated SecuritiesColleagues
- JEJack E. StoverCEO & Executive Chairman
- FSFred S. KnechtelChief Financial Officer
- WMWilliam McMillanCo-founder, Chief Scientific Officer & Head of Research
- DIDavid IckeHead of Digital Health Business
- HCHaeyong ChungIndependent Director
- RJRajesh J. AsorpotaIndependent Director
- PMPeter M. O’RourkeLead Independent Director
- LGLiviu GoldenbergIndependent Director
